OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Self-assembling, pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment
Di Zhu, Yu Lu, Lin Gui, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 5, pp. 2592-2608
Open Access | Times Cited: 20
Di Zhu, Yu Lu, Lin Gui, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 5, pp. 2592-2608
Open Access | Times Cited: 20
Showing 20 citing articles:
Neutrophil extracellular traps in homeostasis and disease
Han Wang, Susan J. Kim, Lei Yu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Han Wang, Susan J. Kim, Lei Yu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
18F- or 177Lu-labeled bivalent ligand of fibroblast activation protein with high tumor uptake and retention
Hongsheng Li, Shimin Ye, Li Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2705-2715
Closed Access | Times Cited: 41
Hongsheng Li, Shimin Ye, Li Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2705-2715
Closed Access | Times Cited: 41
PAD4 and Its Inhibitors in Cancer Progression and Prognosis
Di Zhu, Yu Lu, Yanming Wang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2414-2414
Open Access | Times Cited: 38
Di Zhu, Yu Lu, Yanming Wang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2414-2414
Open Access | Times Cited: 38
PAD4 Inhibitor‐Functionalized Layered Double Hydroxide Nanosheets for Synergistic Sonodynamic Therapy/Immunotherapy Of Tumor Metastasis
Di Zhu, Yu Lu, Shuqing Yang, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 10
Di Zhu, Yu Lu, Shuqing Yang, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 10
Nanotechnology reinforced neutrophil-based therapeutic strategies for inflammatory diseases therapy
Jiahe Wu, Teng Ma, Manning Zhu, et al.
Nano Today (2022) Vol. 46, pp. 101577-101577
Closed Access | Times Cited: 26
Jiahe Wu, Teng Ma, Manning Zhu, et al.
Nano Today (2022) Vol. 46, pp. 101577-101577
Closed Access | Times Cited: 26
Structure–Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy
Yijiang Jia, Renbo Jia, Ayijiang Taledaohan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 335-335
Open Access | Times Cited: 5
Yijiang Jia, Renbo Jia, Ayijiang Taledaohan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 335-335
Open Access | Times Cited: 5
Role of the PADI family in inflammatory autoimmune diseases and cancers: A systematic review
Changhui Zhu, Chunyan Liu, Zhengbin Chai
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Changhui Zhu, Chunyan Liu, Zhengbin Chai
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer
Di Zhu, Yu Lu, Zhanchao Yan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7973-7994
Closed Access | Times Cited: 4
Di Zhu, Yu Lu, Zhanchao Yan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7973-7994
Closed Access | Times Cited: 4
New structural scaffolds to enhance the metabolic stability of arginine-derived PAD4 inhibitors
Yijiang Jia, Sina Bahraminejad, Chenyao Jiang, et al.
Results in Chemistry (2025), pp. 102162-102162
Open Access
Yijiang Jia, Sina Bahraminejad, Chenyao Jiang, et al.
Results in Chemistry (2025), pp. 102162-102162
Open Access
The activation of SIRT1 by resveratrol reduces breast cancer metastasis to lung through inhibiting neutrophil extracellular traps
Wenyan Yu, Zhuning Wang, Ping Dai, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 9, pp. 962-975
Closed Access | Times Cited: 8
Wenyan Yu, Zhuning Wang, Ping Dai, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 9, pp. 962-975
Closed Access | Times Cited: 8
Mitosis targeting in non-small lung cancer cells by inhibition of PAD4
Xiangmei Wu, Liujia Chan, Di Zhu, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27313-e27313
Open Access | Times Cited: 2
Xiangmei Wu, Liujia Chan, Di Zhu, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27313-e27313
Open Access | Times Cited: 2
Neutrophil Extracellular Traps in Tumors and Potential Use of Traditional Herbal Medicine Formulations for Its Regulation
Xiang Li, Lei Hu, Abid Naeem, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2851-2877
Open Access | Times Cited: 2
Xiang Li, Lei Hu, Abid Naeem, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2851-2877
Open Access | Times Cited: 2
Theranostic nanoparticles ZIF-8@ICG for pH/NIR-responsive drug-release and NIR-guided chemo-phototherapy against non-small-cell lung cancer
Kaiming Lu, Xiongfeng Pan, Jinyu Zheng, et al.
Journal of Materials Science Materials in Medicine (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
Kaiming Lu, Xiongfeng Pan, Jinyu Zheng, et al.
Journal of Materials Science Materials in Medicine (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
Stimuli-Responsive Nanomaterials for Tumor Immunotherapy
Xiangpeng Li, Da‐Yong Hou, Jiong-Cheng Wu, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 9, pp. 5474-5495
Closed Access | Times Cited: 2
Xiangpeng Li, Da‐Yong Hou, Jiong-Cheng Wu, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 9, pp. 5474-5495
Closed Access | Times Cited: 2
Acid-switchable nanoparticles induce self-adaptive aggregation for enhancing antitumor immunity of natural killer cells
Xiangshi Sun, Xiaoxuan Xu, Jue Wang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 7, pp. 3093-3105
Open Access | Times Cited: 6
Xiangshi Sun, Xiaoxuan Xu, Jue Wang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 7, pp. 3093-3105
Open Access | Times Cited: 6
Imaging and Therapy of Tumors Based on Neutrophil Extracellular Traps
Yongwei Hao, Dalin Liu, Kaiyuan Wang, et al.
Small Science (2024)
Open Access | Times Cited: 1
Yongwei Hao, Dalin Liu, Kaiyuan Wang, et al.
Small Science (2024)
Open Access | Times Cited: 1
Challenges and Opportunities of Nanomedicine: Novel Comprehensive Approaches for Brain Metastasis
Yufan Xiang, Zhiqian Li, Dayi Pan, et al.
Small Structures (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 3
Yufan Xiang, Zhiqian Li, Dayi Pan, et al.
Small Structures (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 3
The Role of Peptidyl Arginine Deiminase IV(PADI4) in Cancers
Wenjing Wang, Xiangmei Wu, Yuji Wang
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 3, pp. 256-265
Closed Access | Times Cited: 3
Wenjing Wang, Xiangmei Wu, Yuji Wang
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 3, pp. 256-265
Closed Access | Times Cited: 3
PAD4 Inhibitor‐Loaded Layered Double Hydroxide Nanosheets as a Multifunctional Nanoplatform for Photodynamic Therapy‐Mediated Tumor Metastasis Treatment
Rong Chen, Tingting Hu, Lu Yu, et al.
Small (2024)
Open Access
Rong Chen, Tingting Hu, Lu Yu, et al.
Small (2024)
Open Access
Tumor metastasis and recurrence: the role of perioperative NETosis
Zeng Fu, Yuwen Shao, Jingyi Wu, et al.
Cancer Letters (2024) Vol. 611, pp. 217413-217413
Closed Access
Zeng Fu, Yuwen Shao, Jingyi Wu, et al.
Cancer Letters (2024) Vol. 611, pp. 217413-217413
Closed Access
